| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |